← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
298 та иш
Иш: Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer
Cancer immunoediting: from immunosurveillance to tumor escape
Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda +2
Шарҳ мақола20022 иқтибосABIPembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui +24
Мақола20152 иқтибосABIAtezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo +17
Мақола20182 иқтибосABIThe immune contexture in cancer prognosis and treatment
Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès‐Fridman +1
Шарҳ мақола20172 иқтибосABIMitochondria as multifaceted regulators of cell death
Florian J. Bock, Stephen W. G. Tait
Шарҳ мақола20192 иқтибосABINivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro +23
Мақола20192 иқтибосABIPyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Jianjin Shi, Wenqing Gao, Feng Shao
Шарҳ мақола20162 иқтибосABICancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Шарҳ мақола20182 иқтибосABIPembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients
Mao Lin, Haihua Luo, Shuzhen Liang +4
Мақола20202 иқтибосABIPolymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Nataša Avramović, Boris Mandić, Ana Savić-Radojević +1
Шарҳ мақола20202 иқтибосABITumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan +6
Шарҳ мақола20202 иқтибосABI